Cardiac Migration of Endogenous Mesenchymal Stromal Cells in Patients with Inflammatory Cardiomyopathy

Abstract

Introduction. Mesenchymal stromal cells (MSC) have immunomodulatory features. The aim of this study was to investigate the migration and homing potential of endogenous circulating MSC in virus negative inflammatory cardiomyopathy (CMi). Methods. In 29 patients with (n = 23) or without (n = 6) CMi undergoing endomyocardial biopsies (EMB), transcardiac gradients (TCGs) of circulating MSC were measured by flow cytometry from blood simultaneously sampled from aorta and coronary sinus. The presence of MSC in EMB, cardiac inflammation, and SDF-1α mRNA expression were detected via immunohistochemistry and real-time PCR. Results. MSC defined as CD45−CD34−CD11b−CD73+CD90+ cells accounted for 0.010 [0.0025–0.048]%/peripheral mononuclear cell (PMNC) and as CD45−CD34−CD11b−CD73+CD105+ cells for 0.019 [0.0026–0.067]%/PMNC, both with similar counts in patients with or without cardiac inflammation. There was a 29.9% (P < 0.01) transcardiac reduction of circulating MSC in patients with CMi, correlating with the extent of cardiac inflammation (P < 0.05, multivariate analysis). A strong correlation was found between the TCG of circulating MSC and numbers of MSC (CD45−CD34−CD90+CD105+) in EMB (r = −0.73, P < 0.005). SDF-1α was the strongest predictor for increased MSC in EMB (P < 0.005, multivariate analysis). Conclusions. Endogenous MSC continuously migrate to the heart in patients with CMi triggered by cardiac inflammation.

The molecular mechanisms associated with the physiological responses to inflammation and oxidative stress in cardiovascular diseases

“…The chronic low-grade, systemic and local inflammation that develops during obesity links obesity to the development of insulin resistance (Gregor and Hotamisligil 2011 ), which then effects a variety of different organs involved in the control of metabolic homeostasis, including adipose tissue, liver, endocrine pancreas, hypothalamus, and possibly skeletal muscle. As adipocytes are a known source of pro-inflammatory cytokines, including TNF-α, IL-1, and IL-6, obesity can be seen as a chronic inflammatory condition (de Almeida et al 2020 ; Franssen et al 2016 ; Schmidt-Lucke et al 2015 ). These cytokines are known potent stimulators of the production of ROS and NOS by macrophages and monocytes and thereby increasing oxidative stress.…”

The Quest for Antiinflammatory and Immunomodulatory Strategies in Heart Failure

“…MSCs have immunosuppressive properties, although only upon “priming” of MSCs by a specific inflammatory milieu, avoiding potential negative side effects. In addition, MSCs home to injured, inflamed tissue upon intravenous injection . Because the immunomodulatory capabilities of MSCs are not constitutive but rather are licensed by inflammatory cytokines, the net outcomes of MSC activation might vary depending on the levels and the types of inflammation within the tissues in which they reside.…”

Transcriptional Active Parvovirus B19 Infection Predicts Adverse Long-Term Outcome in Patients with Non-Ischemic Cardiomyopathy

“…Due to the virus receptor distribution, B19V persist lifelong within bone marrow precursor cells, and are causative in the vascular endothelium [ 15 ], leading to persistent B19V infection [ 16 , 17 , 18 ]. It is known that endothelial cells represent specific targets in B19V-associated myocarditis [ 19 ].…”